1Sem.·

Gambler in demand?

$RXRX went down well yesterday. It's the most shorted stock in the USA at the moment.

I think I'll risk a little today.


Recursion: Dubai keynote triggers short covering


Recursion's share price rose by a whopping 15 percent yesterday - with extremely high turnover. Yesterday, 179 million shares were traded in the USA. More than ever before for Recursion and six times more than on a normal trading day. There was no official news or analyst recommendation as a trigger. However, the AI conference "Gitex Global" is currently taking place in Dubai and Recursion CEO Chris Gibson gave a keynote speech there yesterday. This keynote was obviously very convincing and probably prompted one or two participants to buy the share. These purchases were made on a stock that is heavily short-sold. In fact, Recursion is the stock with the third highest short ratio of all US stocks with a market capitalization of over one billion dollars. Currently, 30.7 percent of all outstanding shares are sold short, almost one in three.


Apparently, the price increases triggered by the fresh buying yesterday led to short positions being liquidated. This could continue today and in the coming days and drive the share price up (much) further. Especially if the share price also rises above its resistance at 7.15 dollars. Yesterday it closed in the USA at 6.79 dollars. Unfortunately, the Recursion share is not tradable in Germany.

1
5 Commentaires

image de profil
then you can also speculate at $WULF 🤨 🧐 the short rate is also impressive ...
2
image de profil
@Tigawutz but there was no run yesterday because the CEO was speaking at a conference
1
Thanks...have been on my watchlist for a few months. Then you can slowly get in 💪

PS available on flatex :)
1
image de profil
@Investment4Life just bought at 6,95$
1
image de profil
NVIDIA is invested in the share, but it is the weakest investment, hopefully it will develop like the other NVIDIA investments: Nebius, Coreweave, Applied Digitals.

AI Info:
CoreWeave (CRWV): NVIDIA holds about 7% of Class A shares (based on 24.3 million shares). This is the highest relative stake in NVIDIA's portfolio and represents approximately 5-7% of total equity, depending on the consideration of fully diluted shares (approximately 523 million outstanding).
Applied Digital (APLD): NVIDIA holds approx. 2.9 % (based on 7.7 million shares with approx. 269 million shares outstanding).   
Nebius Group (NBIS): NVIDIA holds approx. 0.5 % (based on 1.2 million shares with approx. 239 million shares outstanding).   
Recursion Pharmaceuticals (RXRX): NVIDIA holds approx. 1.8% (based on 7.7 million shares with approx. 437 million shares outstanding).


Yesterday, Google Deepmind with the C2S-Scale Model also had first hypotheses successes with cancer research, it could be that both events or similar further events contribute to a bio-AI euphoria, but in general real results still seem very distant. In the short term, it will only be hype-driven (Ark is also invested), but in the long term it may be a good place to start.

You triggered me and I am now at 6.585 via ING drin✌🏻
Participez à la conversation